Damien Legalloisl

9PUBLICATIONS
17CO-AUTHORS
Disease surveillanceCardiology (incl. cardiovascular diseases)Immunogenetics (incl. genetic immunology)Numerical modelling and mechanical characterisationCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 13, 2026
Temporal trends in characteristics, management and prognosis of patients with acute heart failure through two repeated snapshots.

|Sep 27, 2025
Association Between the Renin-Angiotensin System and Ibrutinib-Related Cardiovascular Adverse Events: A Translational Cohort Study.

Jonaz Font, Amir Hodzic, Angélique Da-Silva

|Jan 01, 2025
Usefulness of dynamic perfusion SPECT with quantitative assessment of myocardial perfusion reserve for the detection of myocardial ischaemia in patients with presumed new left bundle branch block.

Alain Manrique, Clément Guery, Damien Legallois

|Sep 19, 2024
Is ibrutinib-related atrial fibrillation dose dependent? Insights from an individual case level analysis of the World Health Organization pharmacovigilance database.

Joachim Alexandre, Jonaz Font, Da-Silva Angélique

|Nov 14, 2022
Left atrial strain quantified after myocardial infarction is associated with early left ventricular remodeling.

Damien Legallois, Amir Hodzic, Paul Milliez

|Sep 16, 2021
Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis.

Charles Dolladille, Julia Akroun, Pierre-Marie Morice

Pageof 2

Frequent Collaborators

3 joint publications

Charles Dolladille

3 joint publications

Joachim Alexandre

1 joint publications

Pierre-Marie Morice

1 joint publications

Emilien Ezine